Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Threshold Pharmaceuticals names new board member
The company has also announced that Michael Powell steps down from the company’s board of directors. Dr Bird will fill the seat held by Dr Powell, a board
The company has also announced that Michael Powell steps down from the company’s board of directors. Dr Bird will fill the seat held by Dr Powell, a board
Robert Hickey, president and CEO of SyntheMed, said: “SinusShield represents an example of our strategy to capitalize on our proprietary polymer film technology in new surgical applications both
The Nexus-1 and Nexus-2 trials are the company’s pivotal Phase III North American clinical studies for NX-1207. It is anticipated that the trials will enroll over 800 subjects
The partnership focuses on the technological platforms IM and XP-828L developed by Advitech, which have demonstrated in in-vitro and in-vivo preclinical studies the dual ability to accelerate the
The new patents contain claims to a pharmaceutical composition for pain relief containing a narcotic analgesic in micellar form. Rose Perri, COO of Generex, said: “We are pleased
The collaboration has involved shipping frozen samples from two sites in the US to Bangalore for analysis. Peter Berry, president and CEO of CryoPort, said: “Advinus has provided
This strategic collaboration will further the development of Febit’s Geniom technology to detect pathogens more quickly and with increased reliability. The technology development agreement with In-Q-Tel is anticipated
According to the company, NimbleGen comparative genomic hybridization (CGH) 12x135K arrays allow simultaneous analysis of 12 independent sample pairs on a single microarray slide, each with 135,000 empirically
Under the terms of the agreements, in exchange for payment of royalties, Sanofi-Aventis US has agreed to grant Barr and Teva a license to certain patent rights to
The Seer device uses conductive sintered steel as an electrode for radio frequency (RF) for cutting and coagulation. The process involves delivery of RF current and sterile saline